Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Postlingual non-syndromic genetic deafness is a rare, genetically highly heterogeneous otorhinolaryngologic disease, resulting from inner and/or middle ear or hearing nerve anomalies, typically characterized by progressive, bilateral, moderate to profound hearing loss (mean sensorineural hearing impairment equal to 40 dB or more for 500-, 1,000-, and 2,000-Hz frequency tones in the better ear) which occurs after the onset of speech development and is not associated with visible external ear abnormalities or any other medical problems. Language development is not initially significantly delayed.
No clinical trials have been registered for postlingual non-syndromic genetic hearing loss.
13 publications have been identified in PubMed for postlingual non-syndromic genetic hearing loss. Research spans Basic Science / Preclinical (54%), Case Report / Case Series (38%), and Review / Meta-Analysis (8%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 7 | 54% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 10:32 PM UTC
European rare disease database
Patient case studies
5 |
38% |
Research summaries | 1 | 8% |
Wang J (2026). [PMID: 41923037](https://pubmed.ncbi.nlm.nih.gov/41923037/). *BMC Med Genomics*. [Case Report / Case Series]
Koizumi H (2026). [PMID: 41898848](https://pubmed.ncbi.nlm.nih.gov/41898848/). *Genes (Basel)*. [Case Report / Case Series]
Owrang D (2026). [PMID: 41514136](https://pubmed.ncbi.nlm.nih.gov/41514136/). *Mol Neurobiol*. [Basic Science / Preclinical]
Wentling M (2026). [PMID: 41572507](https://pubmed.ncbi.nlm.nih.gov/41572507/). *Adv Sci (Weinh)*. [Basic Science / Preclinical]
Soleimani F (2025). [PMID: 41307816](https://pubmed.ncbi.nlm.nih.gov/41307816/). *Biochem Genet*. [Basic Science / Preclinical]
Han B (2025). [PMID: 39970981](https://pubmed.ncbi.nlm.nih.gov/39970981/). *Neuroscience*. [Review / Meta-Analysis]
Kazemi N (2025). [PMID: 39434538](https://pubmed.ncbi.nlm.nih.gov/39434538/). *Clin Genet*. [Basic Science / Preclinical]
Twumasi Aboagye E (2025). [PMID: 40244166](https://pubmed.ncbi.nlm.nih.gov/40244166/). *Int J Mol Sci*. [Case Report / Case Series]
Courdier C (2025). [PMID: 39610034](https://pubmed.ncbi.nlm.nih.gov/39610034/). *Ophthalmic Genet*. [Basic Science / Preclinical]
He M (2024). [PMID: 39020321](https://pubmed.ncbi.nlm.nih.gov/39020321/). *BMC Med Genomics*. [Case Report / Case Series]